Epitope mapping of the indirect T cell response to allogeneic class I MHC: Sequences shared by donor and recipient MHC may prime T cells that provide help for alloantibody production

Journal of Immunology

Volumn 167, Issue 8, 2001, Pages 4338-4344

  Lovegrove, E ^a   Pettigrew, G J ^a   Bolton, E M ^a   Bradley, J A ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; CD4 ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE;

ALLOIMMUNITY; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; GENETIC VARIABILITY; GRAFT REJECTION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION;

EID: 0035887740     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.8.4338     Document Type: Article

References (51)

1. Direct and indirect recognition: The role of MHC antigens in graft rejection
2. Indirect T cell recognition in allograft rejection
3. Role of indirect allorecognition in allograft rejection
4. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection
5. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides
6. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat
7. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice
8. Indirect recognition of donor HLA-DR peptides in organ allograft rejection
9. Intramolecular and intermolecular spreading during the course of organ allograft rejection
10. Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides
11. Two levels of help for B cell alloantibody production
12. Dominance and crypticity of T cell antigenic determinants
13. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
14. Limited T cell response to donor MHC peptides during allograft rejection: Implications for selective immune therapy in transplantation
15. Indirect allorecognition in solid organ transplantation
16. Fine specificity of peptide determinants for indirect T cell recognition of class I MHC alloantigens
17. + T cell and B cell responses after cardiac allograft rejection
18. Reduction of alloantibody response to class I major histocompatibility complex by targeting synthetic allopeptides for presentation by B cells
19. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts
20. + T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: A role for alloantibody
21. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity
22. Concerted evolution of class I genes in the major histocompatibility complex of murine rodents
23. Improved technique of heart transplantation
24. + thoracic duct lymphocytes to complete allogeneic incompatibilities
25. Interleukin-12 induces interferon-γ-dependent switching of IgG alloantibody subclass
26. T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection
27. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide
28. Disruption of the determinant hierarchy on a self-MHC peptide: Concomitant tolerance induction to the dominant determinant and priming to the cryptic self-determinant
29. The indirect pathway of allorecognition: The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression
30. Structure and repertoire usage of rat TCR alpha-chain genes in T cells infiltrating heart allografts
31. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo
32. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing
33. Induction of T-cell response to cryptic MHC determinants during allograft rejection
34. Induction of T cell responses to a self-antigen following allotransplantation
35. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process
36. Direct and indirect antigen recognition: The pathways to allograft immune rejection
37. The molecular basis of alloreactivity
38. Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy
39. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection
40. Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection
41. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
42. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction
43. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome
44. Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis
45. Modulation by epitope-specific antibodies of class II MHC-restricted presentation of the tetanus toxin antigen
46. Epitope spreading: The role of self peptides and autoantigen processing by B lymphocytes
47. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity
48. Involvement of antibody-dependent apoptosis in graft rejection
49. Antibody-induced transplant arteriosclerosis is prevented by graft expression of antioxidant and anti-apoptotic genes
50. Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: Lack of pro-gression to sclerotic lesions in B cell-deficient mice
51. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo